Kim Hørslev-Petersen Selected Research

Synovitis

1/2022	Erratum corrige: Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
1/2020	Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
10/2017	Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
1/2017	Increased galectin-3 may serve as a serologic signature of pre-rheumatoid arthritis while markers of synovitis and cartilage do not differ between early undifferentiated arthritis subsets.
5/2015	A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.
8/2014	Low-field magnetic resonance imaging or combined ultrasonography and anti-cyclic citrullinated peptide antibody improve correct classification of individuals as established rheumatoid arthritis: results of a population-based, cross-sectional study.
2/2014	Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.
6/2012	Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP.
1/2012	Correlation between computer-aided dynamic gadolinium-enhanced MRI assessment of inflammation and semi-quantitative synovitis and bone marrow oedema scores of the wrist in patients with rheumatoid arthritis--a cohort study.
8/2011	Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kim Hørslev-Petersen Research Topics

Disease

44	Rheumatoid Arthritis 07/2022 - 05/2006
14	Synovitis 01/2022 - 05/2006
10	Pain (Aches) 01/2022 - 08/2008
7	Inflammation (Inflammations) 03/2021 - 01/2010
6	Arthritis (Polyarthritis) 01/2017 - 09/2010
3	Edema (Dropsy) 01/2017 - 08/2011
2	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2017
2	Tenosynovitis 10/2017 - 05/2015
2	Hypertension (High Blood Pressure) 04/2016 - 11/2013
2	Infections 04/2016 - 03/2016
2	Fatigue 03/2014 - 08/2008
1	Necrosis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Back Pain (Backache) 04/2016
1	Multiple Sclerosis 02/2016
1	Osteitis 05/2015
1	Joint Diseases (Joint Disease) 02/2014
1	Psoriatic Arthritis 12/2013
1	Diabetes Mellitus 11/2013
1	Muscle Weakness 10/2010
1	Weight Loss (Weight Reduction) 10/2010
1	type 2 alpha 1 Collagenopathy 06/2010
1	Knee Osteoarthritis 06/2010
1	Osteoarthritis 09/2009
1	Body Weight (Weight, Body) 05/2006
1	Hypertrichosis 05/2006

Drug/Important Bio-Agent (IBA)

8	Methotrexate (Mexate)FDA LinkGeneric 03/2021 - 05/2006
8	Anti-Citrullinated Protein AntibodiesIBA 12/2020 - 04/2009
8	Antirheumatic Agents (DMARD)IBA 01/2018 - 01/2008
7	Rheumatoid FactorIBA 12/2020 - 08/2011
6	ametantrone (HAQ)IBA 09/2018 - 08/2008
5	Adalimumab (Humira)FDA Link 03/2021 - 04/2014
5	C-Reactive ProteinIBA 12/2020 - 06/2012
5	Biological ProductsIBA 12/2020 - 01/2008
4	AutoantibodiesIBA 03/2016 - 06/2010
3	cyclic citrullinated peptideIBA 08/2014 - 04/2009
3	Immunoglobulin M (IgM)IBA 08/2014 - 08/2011
3	Betamethasone (Celestone)FDA Link 06/2012 - 05/2006
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	GlucocorticoidsIBA 01/2017 - 07/2012
2	Triamcinolone (Aristocort)FDA Link 05/2015 - 04/2014
2	Peptides (Polypeptides)IBA 06/2012 - 06/2010
2	SteroidsIBA 02/2012 - 09/2009
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2010 - 05/2006
2	Biomarkers (Surrogate Marker)IBA 02/2008 - 01/2008
1	ChemokinesIBA 07/2022
1	LipidsIBA 03/2021
1	LDL CholesterolIBA 03/2021
1	Abatacept (Orencia)FDA Link 12/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	LigandsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 01/2020
1	Sodium Chloride FDA LinkGeneric 01/2019
1	VitaminsIBA 09/2018
1	Vitamin D FDA LinkGeneric 09/2018
1	1,25-dihydroxyvitamin DIBA 09/2018
1	Circulating MicroRNAIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Galectin 3 (LGALS3)IBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	DisintegrinsIBA 10/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2016
1	ORALIT (ORS)IBA 04/2016
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2016
1	interleukin-20 receptorIBA 03/2016
1	AntigensIBA 02/2016
1	Indicators and Reagents (Reagents)IBA 09/2014
1	Alanine Transaminase (SGPT)IBA 12/2013
1	FicolinsIBA 12/2013
1	Glucose (Dextrose)FDA LinkGeneric 11/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2012
1	GadoliniumIBA 01/2012
1	Cartilage Oligomeric Matrix ProteinIBA 08/2011
1	Aligeron (AS 2)IBA 08/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2010
1	EnzymesIBA 10/2010
1	Prednisolone (Predate)FDA LinkGeneric 10/2010
1	Interleukin-23 (Interleukin 23)IBA 10/2010
1	interleukin-21 (interleukin 21)IBA 10/2010
1	Interleukin-17 (Interleukin 17)IBA 10/2010
1	CytokinesIBA 10/2010
1	amsonic acid (DAS)IBA 09/2010
1	AntibodiesIBA 06/2010
1	Hyaluronic Acid (Hyaluronan)IBA 06/2010
1	CollagenIBA 06/2010
1	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2010
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2010
1	AdiponectinIBA 09/2009
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 04/2009
1	Interleukin-6 (Interleukin 6)IBA 02/2008
1	InterleukinsIBA 02/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	CreatinineIBA 05/2006

Therapy/Procedure

7	Therapeutics 01/2017 - 05/2006
3	Intra-Articular Injections 06/2012 - 06/2010
2	Foot Orthoses 01/2022 - 01/2022
2	Injections 05/2015 - 06/2012
2	Aftercare (After-Treatment) 02/2014 - 07/2012
1	Conservative Treatment 01/2022
1	Ambulatory Care (Outpatient Care) 07/2012